Compare BridgeBio Pharma Inc (BBIO) vs Dominion Energy Inc (D) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Dominion Energy Inc — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Dominion Energy Inc trades at $71.2 (market cap $62.27B). The key difference: Dominion Energy Inc is far larger — about 3.8× BridgeBio Pharma Inc's market cap, and Dominion Energy Inc pays a 3.77% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | D | |
|---|---|---|
Market Cap | $16.27B | $62.27B |
Sector | Health | Utilities |
52-Week High | $90.17 | $71.32 |
52-Week Low | $44.81 | $56.55 |
Enterprise Value | $17.82B | $114.67B |
Dividend Yield | — | 3.77% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →
